Study of Cabozantinib and Nivolumab in Metastatic Castration Resistant Prostate Cancer — StellaPhase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations(4 sites)
United States
University of California San Diego, La Jolla, California University of Chicago Medical Center, Chicago, Illinois University of Texas Southwestern Medical Center, Dallas, Texas University of Wisconsin, Madison, Wisconsin Age range
18 Years and older
Last updated January 2026